This site is about: (1) my professional self, (2) my research into cognition and (3) musings about the intersection of cognition and design.
Jason H. Wong
Basic cognitive research is a necessary component of successful user-centered design. Only through scientific thinking can we make technology intuitive and productive. My goal is to integrate basic research with useful applications.
Mental Doping: The future is here
From an article in The Economist (pdf):
For thousands of years, people have sought substances that they hoped would boost their mental powers and their stamina. Leaves, roots and fruit have been chewed, brewed and smoked in a quest to expand the mind. That search continues today, with the difference only that the shamans work in pharmaceutical laboratories rather than forests. If asked why, the shamans reply that they are looking for drugs to treat the effects of Alzheimer’s disease, attention-deficit disorder, strokes, and the dementias associated with Parkinson’s disease and schizophrenia—and that is the truth. But by creating compounds that benefit the sick, they are offering a mental boost to the healthy, too.
Such drugs are known as cognition enhancers. They work on the neural processes that underlie such mental activities as attention, perception, learning, memory, language, planning and decision-making, usually by altering the balance of the chemical neurotransmitters involved in these processes. This week a report from the Academy of Medical Sciences, a British learned society, says that a large number of such brain-affecting drugs are likely to emerge over the next few decades.
This was likely inevitable. Many diseases of cognition, such as Alzheimer’s, are treated by enhancing cognitive processing. In patients with a disease, this brings them closer to normal cognition. For those who are already functioning normally, the drugs seem to increase their cognitive abilities even further. Alzheimer’s drugs pinpoint memory centers of the brain, Ritalin focuses attention, and the list goes on.
Already, a poll of readers of the journal Nature showed that 20% of readers take some kind of brain-boosting drug. In the highly competitive “publish-or-perish” world of academic research, will taking these drugs be vilified like steroid use, users branded as cheaters? Will scientists need to go through drug testing? Or will this become commonplace so that every professor needs to take them in order to make tenure?
Leave a Reply
You must be logged in to post a comment.